Grand Hôpital de Charleroi
Gilly, Belgium
14 recruiting
Showing 1–14 of 14 trials
Recruiting
Phase 3
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Boehringer Ingelheim4,200 enrolled641 locationsNCT06935370
Recruiting
Phase 3
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Heart Failure
Boehringer Ingelheim6,000 enrolled652 locationsNCT06424288
Recruiting
Phase 3
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Non-small Cell Lung CancerCarcinoma, Non-Small Cell LungCarcinoma, Non-Small-Cell Lung (NSCLC)
Pfizer714 enrolled315 locationsNCT06758401
Recruiting
Phase 3
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Breast Cancer
Pfizer1,020 enrolled518 locationsNCT06760637
Recruiting
Not Applicable
Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume
Radiotherapy Side EffectGlioblastoma
Cliniques universitaires Saint-Luc- Université Catholique de Louvain347 enrolled23 locationsNCT06719440
Recruiting
Phase 3
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
Metastatic HER2-positive Breast Cancer
Jazz Pharmaceuticals550 enrolled166 locationsNCT06435429
Recruiting
Phase 3
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Multiple Myeloma
Pfizer492 enrolled273 locationsNCT06152575
Recruiting
Phase 3
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Multiple Myeloma
Pfizer944 enrolled239 locationsNCT05020236
Recruiting
Not Applicable
A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid Tumours
CNS Metastases
Jules Bordet Institute600 enrolled17 locationsNCT04109131
Recruiting
Prospective Observational Study of Diffuse Large-cell B Lymphoma
Lymphoma, B-Cell
Grand Hôpital de Charleroi50 enrolled1 locationNCT06241729
Recruiting
Phase 2
Study of Lacutamab in Peripheral T-cell Lymphoma
Relapse/RecurrencePeripheral T Cell Lymphoma
The Lymphoma Academic Research Organisation56 enrolled64 locationsNCT04984837
Recruiting
Study on the Clinical Efficacy of Teclistamab
Multiple MyelomaHematologic Diseases
Universitaire Ziekenhuizen KU Leuven100 enrolled17 locationsNCT06477783
Recruiting
Phase 4
Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients
Gastroenteropancreatic Neuroendocrine Tumor
University Hospital, Antwerp270 enrolled19 locationsNCT05701241
Recruiting
Collection of Plasma Samples for Squamous Cell Carcinoma of the Head and Neck Patients
Squamous Cell Carcinoma of the Head and Neck
Cliniques universitaires Saint-Luc- Université Catholique de Louvain400 enrolled5 locationsNCT02139020